Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab govitecan), IgG1

Product Overview

• Article Name: Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab govitecan), IgG1
• Biozol Catalog Number: SYB-CHB262
• Supplier Catalog Number: CHB262
• Alternative Catalog Number: SYB-CHB262-100UG,SYB-CHB262-1MG
• Manufacturer: Sanyou Bio
• Category: Antikörper
• Application: ELISA, FA, FACS, Kinetics
• Species Reactivity: Human
• Alternative Names: IMMU-130, hMN-14-SN38

Product Description

Labetuzumab Govitecan is an antibody-drug conjugate (ADC) containing labetuzumab, a mildly reduced, anti-CEACAM5 humanized monoclonal antibody, conjugated to the potent topoisomerase I inhibitor SN-38, with antineoplastic activity.

Product Properties

• Concentration: 1mg/ml
• Molecular Weight: 157 kDa
• Isotype: IgG1
• NCBI: 06731
• Buffer: 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
• Purity: >90%
• Form: Lyophilized
• Target: CEACAM5 / CEA / CD66e